Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-03-21 to 2022-04-11
Current total value of award: $959.25
Description: 4556670863!ZOLADEX 3.6 MG IMPLANT SYRNS